参考文献/References:
[1] Idolazzi L,Ridolo E,Fassio A,et al.Periostin: the bone and beyond[J].Eur J Intern Med,2017,38:12-16.DOI:10.1016/j.ejim.2016.11.015.
[2] Hu Shidi, Li Xin, Liu Lu, et al. Role of periostin in bone metabolism[J]. Chin J Endocr Metab, 2015, 3(11): 995-999.
[3] Chijimatsu R,Kunugiza Y,Taniyama Y,et al.Expression and pathological effects of periostin in human osteoarthritis cartilage[J].BMC Musculoskelet Disord,2015,16:215.DOI:10.1186/s12891-015-0682-3.
[4] Bolton K,Segal D,McMillan J,et al.Identification of secreted proteins associated with obesity and type 2 diabetes in Psammomys obesus[J].Int J Obes(Lond),2009,33(10):1153-1165.DOI:10.1038/ijo.2009.148.
[5] Michelotti GA,Machado MV,Diehl AM.NAFLD, NASH and liver cancer[J].Nat Rev Gastroenterol Hepatol,2013,10(11):656-665.DOI:10.1038/nrgastro.2013.183.
[6] Luo Y,Qu H,Wang H,et al.Plasma periostin levels are increased in chinese subjects with obesity and type 2 diabetes and are positively correlated with glucose and lipid parameters[J].Mediators Inflamm,2016,2016:6423637. DOI:10.1155/2016/6423637.
[7] Lasselin J,Capuron L.Chronic low-grade inflammation in metabolic disorders:relevance for behavioral symptoms[J]. Neuroimmunomodulation, 2014,21(2-3):95-101. DOI:101159/000356535.
[8] Lu Y,Liu X,Jiao Y,et al.Periostin promotes liver steatosis and hypertriglyceridemia through downregulation of PPARα[J].J Clin Invest,2014,124(8):3501-3513.DOI:10.1172/JCI74438.
[9] Polyzos SA,Kountouras J,Anastasilakis AD,et al.Circulating periostin in patients with nonalcoholic fatty liver disease[J].Endocrine,2017,56(2):438-441.DOI:10.1007/s12020-016-1144-x.
[10] Amara S,Lopez K,Banan B,et al.Synergistic effect of pro-inflammatory TNFα and IL-17 in periostin mediated collagen deposition: potential role in liver fibrosis[J].Mol Immunol,2015,64(1):26-35.DOI:10.1016/j.molimm.2014.10.021.
[11] Mael-Ainin M,Abed A,Conway SJ,et al.Inhibition of periostin expression protects against the development of renal inflammation and fibrosis[J].J Am Soc Nephrol,2014,25(8):1724-1736.DOI:10.1681/ASN.2013060664.
[12] Satirapoj B,Tassanasorn S,Charoenpitakchai M,et al.Periostin as a tissue and urinary biomarker of renal injury in type 2 diabetes mellitus[J].PLoS One,2015,10(4):e0124055.DOI:10.1371/journal.pone.0124055.
[13] Umazume K,Tsukahara R,Liu L,et al.Role of retinal pigment epithelial cell β-catenin signaling in experimental proliferative vitreoretinopathy[J].Am J Pathol,2014,184(5):1419-1428.DOI:10.1016/j.ajpath.2014.01.022.
[14] Yoshida S,Ishikawa K,Asato R,et al.Increased expression of periostin in vitreous and fibrovascular membranes obtained from patients with proliferative diabetic retinopathy[J].Invest Ophthalmol Vis Sci,2011,52(8):5670-5678.DOI:10.1167/iovs.10-6625.
[15] Ishikawa K,Yoshida S,Nakao S,et al.Periostin promotes the generation of fibrous membranes in proliferative vitreoretinopathy[J].FASEB J,2014,28(1):131-142.DOI:10.1096/fj.13-229740.
[16] Tachibana T,Yoshida S,Kubo Y,et al.Reduced vitreal concentration of periostin after vitrectomy in patients with proliferative diabetic retinopathy[J].Acta Ophthalmol,2016,94(1):e81-e82.DOI:10.1111/aos.12752.
[17] Guan J,Liu WQ,Xing MQ,et al. Elevated expression of periostin in diabetic cardiomyopathy and the effect of valsartan[J].BMC Cardiovasc Disord,2015,15:90.DOI:10.1186/s12872-015-0084-3.
相似文献/References:
[1]夏心怡 张洪梅.肠道菌群及其代谢产物调节糖脂代谢的机制[J].国际内分泌代谢杂志,2018,38(05):309.[doi:10.3760/cma.j.issn.1673-4157.2018.05.006]
Xia Xinyi,Zhang Hongmei.Regulating mechanism of glycolipid metabolism by intestinal microbiota and its metabolites[J].International Journal of Endocrinology and Metabolism,2018,38(01):309.[doi:10.3760/cma.j.issn.1673-4157.2018.05.006]
[2]沈祯敏 邵莉.整合素相关蛋白及其配体在糖脂代谢中的作用[J].国际内分泌代谢杂志,2018,38(05):336.[doi:10.3760/cma.j.issn.1673-4157.2018.05.013]
Shen Zhenmin,Shao Li.Roles of integrin associated protein and its ligands in glucose and lipid metabolism[J].International Journal of Endocrinology and Metabolism,2018,38(01):336.[doi:10.3760/cma.j.issn.1673-4157.2018.05.013]
[3]严克敏 朱惠娟 龚凤英.红花黄色素改善肝功能和糖脂代谢作用的研究进展[J].国际内分泌代谢杂志,2019,39(02):97.[doi:10.3760/cma.j.issn.1673-4157.2019.02.006]
Yan Kemin,Zhu Huijuan,Gong Fengying.Advances in the roles of safflower yellow in improving liver function and glucose and lipid metabolism[J].International Journal of Endocrinology and Metabolism,2019,39(01):97.[doi:10.3760/cma.j.issn.1673-4157.2019.02.006]
[4]郭青玉 邵加庆.大黄酸改善糖脂代谢的相关机制[J].国际内分泌代谢杂志,2019,39(03):207.[doi:10.3760/cma.j.issn.1673-4157.2019.03.015]
Guo Qingyu,Shao Jiaqing.Related mechanisms of Rhein improving glucose and lipid metabolism[J].International Journal of Endocrinology and Metabolism,2019,39(01):207.[doi:10.3760/cma.j.issn.1673-4157.2019.03.015]
[5]贺琼 薄佳琪 张梦圆 王维 何传辉 刘云峰.骨膜蛋白在糖尿病心肌病发病中的作用[J].国际内分泌代谢杂志,2020,40(04):271.[doi:10.3760/cma.j.issn.1673-4157.2020.04.013]
He Qiong,Bo Jiaqi,ZhangMengyuan,et al.Role of periostin in the pathogenesis of diabetic cardiomyopathy[J].International Journal of Endocrinology and Metabolism,2020,40(01):271.[doi:10.3760/cma.j.issn.1673-4157.2020.04.013]
[6]杜苏苏,李晓南.姜黄素对非酒精性脂肪性肝病的调控作用[J].国际内分泌代谢杂志,2020,40(06):399.[doi:10.3760/cma.j.cn121383-20200117-01026]
Du Susu,Li Xiaonan.Regulatory effects of curcumin on nonalcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2020,40(01):399.[doi:10.3760/cma.j.cn121383-20200117-01026]
[7]梁源,孙立君,尹悦,等.消化内分泌与糖脂代谢[J].国际内分泌代谢杂志,2021,41(04):290.[doi:10.3760/cma.j.cn121383-20210415-05028]
Liang Yuan,Sun Lijun,Yin Yue,et al.Gut endocrine in glucose and lipid metabolism[J].International Journal of Endocrinology and Metabolism,2021,41(01):290.[doi:10.3760/cma.j.cn121383-20210415-05028]
[8]李小红,陈频.新型脂肪细胞因子Metrnl在糖脂代谢中作用的研究进展[J].国际内分泌代谢杂志,2022,42(02):138.[doi:10.3760/cma.j.cn121383-20201027-10034]
Li Xiaohong,Chen Pin..Research progress on the role of novel secretory adipokine-Metrnl in glucose and lipid metabolism[J].International Journal of Endocrinology and Metabolism,2022,42(01):138.[doi:10.3760/cma.j.cn121383-20201027-10034]
[9]杨亚梅,朱惠娟.催产素对摄食及糖脂代谢调节作用的研究进展[J].国际内分泌代谢杂志,2023,43(01):54.[doi:10.3760/cma.j.cn121383-20210426-04069]
Yang Yamei,Zhu Huijuan..Research progress of oxytocin on eating behavior and glycolipid metabolism regulation[J].International Journal of Endocrinology and Metabolism,2023,43(01):54.[doi:10.3760/cma.j.cn121383-20210426-04069]
[10]胡雯婧,朱惠娟,龚凤英.成纤维细胞生长因子21治疗肥胖症及其相关代谢性疾病的研究进展[J].国际内分泌代谢杂志,2023,43(02):117.[doi:10.3760/cma.j.cn121383-20220125-01048]
Hu Wenjing,Zhu Huijuan,Gong Fengying..Research progress of fibroblast growth factor 21 in the treatment of obesity and its associated metabolic diseases[J].International Journal of Endocrinology and Metabolism,2023,43(01):117.[doi:10.3760/cma.j.cn121383-20220125-01048]